title: PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.
authors.affiliation: Departments of aGenetics bBioengineering, Stanford University, Palo Alto, California cDepartment of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville, Kentucky, USA dDepartment of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece eDepartment of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden.
authors.forename: Ellen M
authors.initials: EM
authors.lastname: McDonagh
authors.forename: Sotiria
authors.initials: S
authors.lastname: Boukouvala
authors.forename: Eleni
authors.initials: E
authors.lastname: Aklillu
authors.forename: David W
authors.initials: DW
authors.lastname: Hein
authors.forename: Russ B
authors.initials: RB
authors.lastname: Altman
authors.forename: Teri E
authors.initials: TE
authors.lastname: Klein
mesh_terms: D000483:Alleles; D001191:Arylamine N-Acetyltransferase / Q000235:genetics*; D002110:Caffeine / Q000493:pharmacokinetics; D020869:Gene Expression Profiling; D023281:Genomics; D005838:Genotype; D006801:Humans; D006830:Hydralazine / Q000493:pharmacokinetics; D007527:Isoenzymes / Q000235:genetics; D007538:Isoniazid / Q000493:pharmacokinetics; D010597:Pharmacogenetics; D010641:Phenotype; D011110:Polymorphism, Genetic; D013420:Sulfamethoxazole / Q000493:pharmacokinetics; D012460:Sulfasalazine / Q000493:pharmacokinetics; D015262:Xenobiotics / Q000737:chemistry
chemical_list: D007527:Isoenzymes; D015262:Xenobiotics; D006830:Hydralazine; D002110:Caffeine; D012460:Sulfasalazine; D001191:Arylamine N-Acetyltransferase; C089384:N-acetyltransferase 1; C478900:NAT2 protein, human; D013420:Sulfamethoxazole; D007538:Isoniazid